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SUMMARY
The risk factors for time to mortality, censored at 30 days, of patients admitted to an adult teaching hospital ICU with
haematological and solid malignancies were assessed in a retrospective cohort study. 
Patients, demographics and daily ICU patient data, from admission to day 8, were identified from a prospective
computerized database and casenote review in consecutive admissions to ICU with haematological and solid
tumours over a 10-year period (1989-99). The cohort, 108 ICU admissions in 89 patients was of mean age (±SD)
55±14 years; 43% were female. Patient diagnoses were leukaemia (35%), lymphoma (38%) and solid tumours
(27%). Median time from hospital to ICU admission was five days (range 0-67). On ICU admission, 50% had septic
shock and first day APACHE II score was 28±9. Forty-six per cent of patients were ventilated. ICU and 30-day
mortality were 39% and 54% respectively. Multivariate Cox model predictors (P<0.05), using only ICU admission
day data were: Charlson comorbidity index (CCI), time to ICU admission (days) and mechanical ventilation. For
daily data (admission through day 8), predictors were: cohort effect (2nd vs 1st five-year period); CCI; time to ICU
admission (days); APACHE II score and mechanical ventilation.
Outcomes were considered appropriate for severity of illness and demonstrated improvement over time. Ventilation
was an independent outcome determinant. Controlling for other factors, mortality has improved over time (1st vs 2nd
five year period). Analysis restricted to admission data alone may be insensitive to particular covariate effects. 
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The role of the intensive care unit (ICU) in the
care of critically ill patients with haematological and
solid malignancies has been a matter of contro-
versy1-4. Recent reports suggest that the outcome of
these patients may not have substantially improved
over time5-8. The impact on survival of various inter-
ventions such as prior bone marrow transplantation
(BMT; allogeneic or autologous), mechanical ventila-
tion and multiple organ dysfunction and its treat-
ment(s) has been variously assessed; outcome varia-
tions being presumably due to patient-specific factors
(solid tumour versus haematological malignancy,
medical versus surgical) and illness severity, and
aetiology (respiratory failure and/or shock, extent 
of associated neutropaenia and proximity to chemo-
therapy). 
Using a previously defined methodology9 we re-
viewed potential risk factors for time-to-mortality,
censored at 30 days post-ICU-admission, of patients
admitted to a single multidisciplinary adult ICU at a
university teaching hospital, over the 10-year period
1989 to 1999. Primarily, we were concerned to
evaluate any change in outcome over time10; the effect
of severity of illness11, comorbidity burden12 and
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mechanical ventilation13 on outcome. Secondarily, 
we gauged the ability of Cox regression to ade-
quately model survival, given recent cautions that the
Cox model may not be optimal in acute severe ill-
ness14, and sought evidence for latent patient hetero-
geneity about important covariates (cohort effect 
and mechanical ventilation) using random effects
models15.
METHODS
All ICU patient admissions with haematological or
solid malignancies from 1989 to 1999, directly
referred by the haematology-oncology unit, were
identified from the prospective ICU computerized
database, incorporating the APACHE II scoring
system. Casenotes and ICU data sheets of the
patients were subsequently reviewed to confirm diag-
noses and to extract relevant study data (which had
not been recorded in the computerized ICU data-
base). Access to these records was obtained under
extant guidelines of The Queen Elizabeth Hospital
(TQEH) Ethics of Research Committee and
informed consent was waived.
The following data were extracted by two in-
vestigators independently (PJS, JLM):
1. Baseline demographics and diagnosis: date of
birth and gender; nature and initial time of malig-
nancy diagnosis; Karnofsky score16. Information
was obtained from hospital sources and referring
medical officers.
2. Hospital admission data: cohort (1st five years
October 1989-July 1994; 2nd five years: August
1994-March 1999); admission status (index admis-
sion, repeat hospital and ICU admission or repeat
ICU admission within a hospital admission);
Charlson comorbidity score (CCI)17; ICU admis-
sion diagnosis; source (ward or emergency ser-
vice); hospital admission to ICU admission time
(lead time); recent surgery (within seven days);
time of last chemotherapy; performance of stem
cell transplantation; prescription on ICU admis-
sion of steroid, granulocyte colony-stimulating
factor [G-CSF] and antibiotics; leucocyte and
platelet count on ICU admission, on days 1
(admission) through 8 following ICU admission;
details of mechanical ventilation, ICU thera-
peutics, APACHE II score (recorded on admission
from the ICU database and calculated retrospec-
tively for subsequent days), organ failure18 and
sepsis status (noted as systemic inflammatory
syndrome (SIRS), sepsis, severe sepsis and septic
shock)19 on days 1 (admission) through 8 following
ICU admission; ICU and hospital length of stay
and outcome.
3. Follow-up—casenote and computerized informa-
tion systems review and telephone contact with
local medical officers. 
Patient Exclusions
To preserve a uniform cohort, only patients being
directly cared for by the haematology-oncology unit
were included in the review. Thus, for example,
cancer patients being subjected to “routine” surgical
resection and such patients referred from the surgical
wards to the ICU for postoperative complications,
were not considered. The haematology-oncology unit
is a stand-alone integrated unit, caring for a wide
range of haematological and solid malignancies;
during the time of review, allogeneic bone marrow
transplants were not recorded.
Statistical Methodology
Variables are reported as mean±SD. Interval data
were analysed by t-test and categorical data by Fisher
exact test, where appropriate. Stata(r) statistical soft-
ware (Version 8 SE, Stata Corp, College Station, TX)
was used. 
Time to mortality for the index admissions, right
censored at day 30, was assessed using Kaplan-Meier
and Cox model estimates. The Cox model was struc-
tured for (i) pre-morbid and ICU admission day
variables and (ii) pre-morbid, admission day and ICU
day 1 to 8 time-varying covariates using both first
degree lagged and differenced values20. Time-varying
covariates were identified as those having significant
interactions (P<0.05) of the (continuously time-
varying) covariate with failure times (time to death)
over 30 days. Predictor variables were identified using
a backward selection procedure based on the Akaike
information criterion21; initial bi-variable selection
screening was not undertaken22. Specific attention
was directed to (i) model selection with correlated
variables (ii) the potential effect of multi-colinearity
(iii) the presence of (first order) interactions and (iv)
non-linearity of covariate effect. Overall Cox model
fit was assessed by residual plots and specific tests for
goodness-of-fit, concordance (Harrell’s C statistic)
and non-proportionality23,24.
The Cox analysis for multiple record patient data
(days 1 through 8) was extended to a random effects
model using the Stata® module GLLAMM25. Mor-
tality was modelled using a Poisson analysis and the
exponentiated regression coefficients were inter-
preted as conditional hazard ratios. The baseline log
hazard was modelled via restricted cubic splines26. For
instances observed within subjects (785 within 89
patients), random effects were modelled at the sub-
ject level and both the ventilation and cohort effect
were also allowed to vary randomly between subjects.
Overall utility of the random effects model compared
with the fixed effects Poisson model was determined
by the likelihood ratio test. Frailty variance [θ],
defined as the exponential of the random intercept,
was reported; values of >1 were interpreted as re-
flecting a greater than average hazard and for <1, the
hazard was less than average24.
RESULTS
During the study period there were 108 admissions
in 89 patients (13 admissions were repeat ICU admis-
sions in a hospital admission and there were six
repeat hospital and ICU admissions). Fifty-four per
cent of admissions were in the early cohort. ICU
admission diagnoses and patient variables are pre-
sented in Table 1. 
Graphical display of the time change (days 1
(admission) through 8) for 30-day survivors vs non-
survivors for (i) APACHE II score, white blood cell
(WBC) count, platelet count and plasma bilirubin
and (ii) percentage of patients ventilated, inotrope-
dependent, cardiovascular, respiratory, renal, haema-
tologic and neurologic failure18, are presented in
Figures 1 and 2 respectively. The most apparent dif-
ferences over time between 30-day survivors versus
non-survivors were for the APACHE II score, venti-
lation and haematological and neurologic failure. For
variables WBC and platelet count and plasma bili-
rubin, due to skewness of distribution, time points
were plotted as median, interquartile range. 
Overall, 46% of patients were ventilated in ICU.
Ventilated patients had an APACHE II score 34±8,
with 73% mortality. For the early versus late cohort,
there was no difference in APACHE II score (28±8.4
vs 28±10, P=0.9), the percentage of patients venti-
lated (56% vs 44%, P=0.99) or unadjusted mortality
(78% vs 67%, P=0.49). Median length of mechanical
ventilation was 3.5 days (range, 0.5-26 days); median
ICU and hospital length of stay were 3 (range, 0.5-41)
and 20 (range, 0.5-141) days respectively. ICU and
30-day mortality were 39% (95% CI, 30%-52%) and
54% (95% CI: 45%-65%) respectively. 
Kaplan-Meier estimates of 30-day survival proba-
bility and the corresponding smoothed hazard plot27
are shown in Figure 3 A and B respectively. Using
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TABLE 1
Patient variables
ICU referral diagnosis (n, (%))
Septic shock 28 (25.93)
Acute respiratory failure (non-specific) 23 (21.30)
Sepsis 22 (20.37)
Pneumonia 13 (12.04)
Hypovolaemic shock 8 (7.40)
Tumor lysis syndrome 6 (5.56)
Cardiac arrest 3 (2.78)
Pulmonary embolus 2 (1.85)
Status epilepticus 2 (1.85)
Gastrointestinal perforation 1 (0.93)
Pre-morbid
Malignancy diagnosis (%)
Leukemia (acute & chronic) 35
Lymphoma (+ multiple myeloma) 38
Solid tumour 27





Karnofsy score (%) 57 (22)
Charlson comorbidity index* 3 (range 2-12)
ICU Admission
Chemotherapy within 30 days (%) 57
Stem cell transplant (%) 20
Steroid on admission (%) 40
G-CSF on admission (%) 18
Age (years) 54.5 (14)
Gender (% female) 43
Lead time (days) * 5 (range 0-67)
APACHE II score 28 (9)
WCC*# 1.2 (0.1-45.8)
Platelet count*# 32 (2-552)
Ventilated (%) 34
Inotropes / vasopressors (%) 50
SIRS (%) 99
Sepsis (%) 81.5
Severe sepsis (%) 66
Septic shock (%) 50
*Median (range); #×109/l
TABLE 2
Cox model estimates (hazard ratio±SE) for significant predictors
Cohort CCI Time to ICU Apache II Mechanical
(2nd vs 1st (range 2-12) admission score ventilation
5 year period) (days)
Admission day Data
Hazard Ratio ± SE 1.15±0.063 1.02±0.012 3.21±0.981
P value 0.009 0.05 0.001
Admission to day 8 Data
Hazard Ratio±SE 0.62 ± 0.20 1.12±0.056 1.02±0.001 1.05±0.023 2.59±0.723
P value 0.05 0.02 0.02 0.02 0.01
CCI: Charlson comorbidity index. 
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FIGURE 1: Time course of change of variables for survivors (dashed line) and non-survivors (dotted line) over the first 8 days of ICU stay. 
A. APACHE II score (as mean values with vertical bars as 95% CI). 
B. Leucocyte count (109/l). 
C. Platelet count (109/l) .
D. Plasma bilirubin (mmol/l).
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FIGURE 2: Time course of change of variables (as percentages) for survivors (dashed line) and non-survivors (dotted line) over the first 8
days of ICU stay. 
Upper panel, left to right: ventilation, inotrope dependence and cardiovascular failure.
Middle panel, left to right: respiratory, renal and haematologic failure.
Lower panel: neurologic failure.
Criteria for organ failures are as in Methods section, above.
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admission day data only, Cox regression predictors 
of survival were: Charlson comorbidity index, lead
time (in days) and mechanical ventilation. For the
multiple-record data Cox model (using patient data
over days 1-8 in ICU), predictors of survival were
Charlson comorbidity index, lead time (in days),
mechanical ventilation, APACHE II score and cohort
effect (considered as a categorical variable; second
versus first five-year period) (Table 2). Multi-
colinearity was not present and no significant inter-
actions were evident despite careful consideration of
the potential interactions between (i) lead time and
cohort effect (ii) cohort effect and malignancy diag-
nosis (iii) mechanical ventilation, APACHE II score
and malignancy diagnosis (iv) inotrope dependency
and APACHE II score and (v) age at diagnosis and
specific malignancy diagnosis. Non-linear covariate
effect was not demonstrated. 
The Cox model demonstrated good fit (P>0.1
across all deciles), Harrell’s C concordance statistic
was 0.70 and the global proportionality test was non-
significant at P=0.16 (Day 1 model) and P=0.9 (mul-
tiple patient record data model). Time-varying
covariate effects were not found for any variables,
including the predictors noted above, WBC count,
platelet count, and inotrope dependency. Graphical
display of the survival probabilities for the four dis-
tinct categorical groups (multiple record patient data
model), at covariate values of APACHE II score=26,
CCI=4 and lead time=5 days, is presented in Figure
4 (back-projected to a common survival probability of
100% at day “0”).
Table 3 presents parameter estimates from the ran-
dom effects model: the Cox and fixed effects Poisson
models yielded similar estimates for the predictor
variables (Charlson comorbidity index, lead time,
mechanical ventilation, APACHE II score and
cohort) signifying that the modelling of the baseline
hazard was sufficient. The random effects model
parameters suggested an increased impact of both the
cohort effect and mechanical ventilation. However,
the likelihood ratio test comparing this model with
the fixed effects Poisson model was non-significant 
(P>0.5), indicating no unmeasured subject hetero-
geneity.
FIGURE 3: A. Kaplan-Meier survival estimates with 95% point-wise CIs (dashed lines). B. Smoothed hazard (vertical axis) with 95% CIs
(dashed lines); horizontal axis; time(days).
TABLE 3
Comparison of Cox, fixed effect Poisson and random effects regres-
sion model estimates 
Cox model Poisson GLLAMM θ
Cohort (2nd vs 1st 
5 year period) 0.62±0.2 0.61±0.19 0.54±0.207 1.03
CCI 1.12±0.056 1.12±0.06 1.16±0.082
TIME to ICU 
admission
(days) 1.02±0.009 1.02±0.01 1.02±0.013
APACHE II score 1.05±0.023 1.05±0.022 1.06±0.025
Mechanical 
ventilation 2.59±0.723 2.61±0.868 3.07±1.344 1.02
Log Likelihood –185.72 –148.5 –148.28
Cox model: estimates as hazard ratios±SE for multiple record
patient data (days 1-8, cf Figure 5). Poisson; fixed effects Poisson
model with baseline hazard modelled with restricted cubic spline
(point estimates as incidence rate ratios±SE). GLLAMM; ran-
dom effects model (subject, mechanical ventilation and cohort),
estimates as conditional hazard ratios±SE. θ: frailty variance.
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DISCUSSION
Numerous articles have reviewed the outcome of
ICU patients suffering from haematological and solid
tumours and have addressed the question of pre-
dictive variables at a descriptive2,28-30 and modelling
level 8,31-34. A dominant theme has been the poor out-
come, with hospital or 30-day mortalities ranging
from 40 to 50% in general cancer patients5, and up 
to 80% or greater in ventilated, inotrope-dependent
patients undergoing bone marrow transplantation3.
Not surprisingly, mortality has also been observed to
increase with severity of illness. The current study
attests to a high mortality, revealed by the patient
subsets displayed in Figure 4. 
Modelling Considerations
The analytic approach was to contrast the more
conventional premorbid/admission variable analysis
with that of an “updated” covariate model, using
patient data recorded over the first eight days of ICU
admission. As noted above, no time-varying covariate
effect for the predictors could be demonstrated and
thus, in the “updated” covariate model, the coeffi-
cients were interpreted as an “average” over all days
for which failures occurred. That is, the coefficients
representing covariate effect were “time-invariant”20.
Of interest, no prognostic effect of tumour type or
leukocyte or platelet count (at least over the first 8
days) was evident, which would argue against any
policy of optimism that depended upon recovery of
haematological indices. 
Neither the cohort effect nor the APACHE II score
were predictors using the day 1 data set, which would
therefore indicate advantage for the “updated”
covariate model. The improvement of statistical effi-
ciency by repeated subject observation (in the pres-
FIGURE 4: Cox model survival probabilities for the 4 distinct categorical groups (multiple record patient data model), at covariate values of:
APACHE II score=26, CCI=4 and lead time=5 days (back-projected to a common survival probability of 100% at day “0”).
Circles: late cohort, no mechanical ventilation.
Squares: early cohort, no mechanical ventilation.
Diamonds: late cohort, mechanical ventilation.
Triangles: early cohort, mechanical ventilation.
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ence of information loss due to censoring), has been
previously noted35. 
The (mortality) hazard over the 30 days showed a
monotonic decline (Figure 3B), which was different
from the peaked (non-monotonic) hazard curve
reported by Knaus and co-workers14. A monotonic
decline suggests a maximal hazard on or before ICU
admission, indicated presumably by the high ad-
mission APACHE II scores and the predictive
importance of time to ICU admission. 
The cohort effect in this study was modelled as a
categorical variable as this approach had an intuitive
interpretability and was a compromise between a long
study period (10 years) and relatively small study
numbers. There are problems with such a “cut-point”
approach: those of increase in Type I error, over-
estimation of effect at each of the cut-point levels and
the conceptual problem of sudden marked changes in
effect at the various levels36. A post hoc search for an
“optimal cut-point” for the cohort effect (using the
maximal chi-square of the generalized log-rank statis-
tic via isotonic regression analysis37) identified the
same cut-point (July to August 1994) as was used in
the study (data not shown). 
Cohort Effect
A cohort effect was demonstrated, with the second
five-year period having a better (risk adjusted) prog-
nosis (Table 3). That this was not an effect of a change
in referral pattern or severity and/or type of illness
was indicated by the non-significance of the inter-
action between the cohort effect and lead-time,
APACHE II score and tumor diagnosis. There was
also no difference in the percentage of censored
patients, nor in the distribution of censored survival
times, early versus late cohort (P=0.13, P=0.9,
respectively), which could have potentially explained
this cohort effect. 
There would appear to be little comment in the
specific haematological-oncological literature about
ICU mortality improvement over time: two recent
notes have suggested that this may not be the case7,38.
However, Azoulay et al39 reported a single institu-
tion study with an improved survival in a 1996 to 
1998 cohort compared with a 1990 to 1995 cohort and
proposed that the increased use of non-invasive
mechanical ventilation over time was a possible
explanation for the survival improvement, although 
a (significant) treatment-cohort interaction was not
reported. While the use of non-invasive mechanical
ventilation may explain the improvements seen 
over time, the interpretation of treatment effects
(causality) is known to be problematic in cohort
studies40 and the positive effect of non-invasive
mechanical ventilation on mortality in randomized
studies involving non-COPD patients has yet to be
demonstrated41. Furthermore, an analysis of the dif-
ferences between patients who received non-invasive
mechanical ventilation to those who did not, yielded
differences (P<0.1) in seven patient characteristics,
six of which favoured improved outcomes in the non-
invasive mechanical ventilation patients, suggesting
that other changes in patient characteristics over time
may have made this form of ventilation look more
favourable.
The factor(s) responsible for the improvements
over time in the current study were not immediately
apparent. Overall power considerations may have
been important, especially in the detection of treat-
ment effects through the use of interaction terms,
given the requirement for increased patient numbers
(approximately 4×) to demonstrate significance of
interactions as compared with the main effects42. It is
possible that the observed improvement in outcome
with time may be consonant with the overall improve-
ment in ICU outcomes noted by Azoulay et al39 and
Kress et al43 and identified in other specific patient
groups10. 
IMPACT OF MECHANICAL VENTILATION
Most studies have found mechanical ventilation to
be an independent adverse predictor of outcome, as
with the present report. Some cautions may apply to
the interpretation of the effect of mechanical ventila-
tion. There was significant statistical association
between APACHE II score, mechanical ventilation
use and inotrope dependency (data not shown).
Ventilation may also be considered as a surrogate for
outcome, as in the paper by Crawford and Peterson44.
Thus, within the same data sets, these outcomes are
correlated and, therefore, it may be no surprise to
find a significant effect of ventilation. The bias of esti-
mators that adjust for a concomitant variable affected
by treatment has been noted40. This being said, no
colinearity was demonstrated between APACHE II
score, mechanical ventilation and inotrope depen-
dency and there was no substantive change in the
point estimates and standard errors of the hazard
ratios of the Charlson comorbidity index, lead-time,
APACHE II score and cohort when mechanical ven-
tilation (considered as a categorical variable) was
excluded from the estimation. This would suggest
that the estimates of the effect of mechanical ventila-
tion obtained in this study were not biased by overly
strong correlations with other variables.
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Premorbid Assessment
Although the APACHE II score incorporates an
assessment of chronic health status, the predictive
ability of other composite chronic health indices,
Karnofsky score and Charlson comorbidity index, was
also assessed. The Karnofsky score was not found to
be predictive. Other referenced studies used uni-
variate assessment of chronic health status, which is
paradoxical as the multivariable Charlson index17,
introduced in 1987, was validated in a cohort of
patients with breast cancer and has been found to be
of predictive value in other patient groups45. 
Random Effects (Frailty) Model
The notion of frailty or individual (or group)
heterogeneity and its extension to survival studies 
has assumed some importance recently15. A frailty
model is a random effects model for time variables
where the random effect has a (latent) multiplicative
effect on the hazard. Frailty addresses unexplained
variability (in time to failure) in terms of omitted
covariate(s) or measurement error; thus, if frailty is
ignored, an underestimation of covariate effect will
be observed46. The use of frailty in this analysis was to
identify patient heterogeneity with respect to both
ventilation and cohort effect, where some uncertainty
existed about the adequacy of modelling of the effect.
This may be particularly apposite in indicating
“system” (treatment and case-composition) changes
over time that were unable to be precisely specified
from the data set. Although the random effects point
estimates suggested a modification of the effect of 
the covariates (Table 3), we were unable to demon-
strate significant advantage for the random effects
approach. 
CONCLUSIONS
We would conclude that 30-day survival improved
over a 10-year period. Questions of excess mortality
or appropriateness of care must be considered
against the background of the level of severity of ill-
ness and cohort composition, including comorbidity
burden. Analysis restricted to admission data alone
may be insensitive to particular covariate effects.
Neither tumour type nor recovery of neutrophil or
platelet count over first eight days after admission
was prognostic, but mechanical ventilation would
appear to be an independent mortality determinant.
Peak mortality hazard occurs proximate to ICU
admission and declines monotonically thereafter.
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